Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatic Metastasis from Breast Cancer.

Literature DB >> 33328708

Hepatic Metastasis from Breast Cancer.

Abstract

Breast cancer is the most common cancer in women and breast cancer liver metastasis may be associated with poor outcomes. Emerging locoregional therapies can be given in outpatient settings or with short hospital stays, to provide local control, support quality of life, preserve liver function, and potentially prolong survival. This review discusses retrospective studies suggesting potential benefits of locoregional treatment of breast cancer liver metastasis. Future prospective studies are needed to demonstrate efficacy and optimize patient selection. Thieme. All rights reserved.

Entities: Disease Species

Keywords: ablation; breast cancer; chemoembolization; hepatic metastasis; locoregional; radioembolization

Year: 2020 PMID： 33328708 PMCID： PMC7732569 DOI： 10.1055/s-0040-1720949

Source DB: PubMed Journal: Semin Intervent Radiol ISSN： 0739-9529 Impact factor: 1.513

64 in total

Review 1. Interventional radiology in breast cancer.

Authors: Lizbeth Moira Kenny; Franco Orsi; Andreas Adam
Journal: Breast Date: 2017-07-10 Impact factor: 4.380

2. Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients.

Authors: M Barral; A Auperin; A Hakime; V Cartier; V Tacher; Yves Otmezguine; L Tselikas; T de Baere; F Deschamps
Journal: Cardiovasc Intervent Radiol Date: 2016-02-09 Impact factor: 2.740

3. Intrahepatic and systemic therapy with oxaliplatin combined with capecitabine in patients with hepatic metastases from breast cancer.

Authors: D L Nielsen; H Nørgaard; L W Vestermark; P Pfeiffer; B K Jensen; K M Nelausen; M Bergenfeldt; K L Hermann; B V Jensen
Journal: Breast Date: 2012-06-04 Impact factor: 4.380

4. Association of PI3K Pathway Mutations with Early Positron-Emission Tomography/CT Imaging Response after Radioembolization for Breast Cancer Liver Metastases: Results of a Single-Center Retrospective Pilot Study.

Authors: Amy R Deipolyi; Christopher C Riedl; Jacqueline Bromberg; Sarat Chandarlapaty; Christopher A Klebanoff; Constantinos T Sofocleous; Hooman Yarmohammadi; Lynn A Brody; F Edward Boas; Etay Ziv
Journal: J Vasc Interv Radiol Date: 2018-08-03 Impact factor: 3.464

5. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.

Authors: Affaan K Bangash; Bassel Atassi; Virginia Kaklamani; Thomas K Rhee; Maurice Yu; Robert J Lewandowski; Kent T Sato; Robert K Ryu; Vanessa L Gates; Steven Newman; Robert Mandal; William Gradishar; Reed A Omary; Riad Salem
Journal: J Vasc Interv Radiol Date: 2007-05 Impact factor: 3.464

6. Aggressive treatment for hepatic metastases from breast cancer: results from a single center.

Authors: F Polistina; G Costantin; A Febbraro; E Robusto; G Ambrosino
Journal: World J Surg Date: 2013-06 Impact factor: 3.352

7. Radioembolization in patients with hepatic metastases from breast cancer.

Authors: Tobias F Jakobs; Ralf-Thorsten Hoffmann; Ton Fischer; Hans-Joachim Stemmler; Klaus Tatsch; Christian La Fougere; Ravi Murthy; Maximillian F Reiser; Thomas K Helmberger
Journal: J Vasc Interv Radiol Date: 2008-03-19 Impact factor: 3.464

8. Radiofrequency ablation in the management of liver metastases from breast cancer.

Authors: C T Sofocleous; R G Nascimento; M Gonen; M Theodoulou; A M Covey; L A Brody; S M Solomon; R Thornton; Y Fong; G I Getrajdman; K T Brown
Journal: AJR Am J Roentgenol Date: 2007-10 Impact factor: 3.959

Review 9. Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials.

Authors: G Atalay; L Biganzoli; F Renard; R Paridaens; T Cufer; R Coleman; A H Calvert; T Gamucci; A Minisini; P Therasse; M J Piccart
Journal: Eur J Cancer Date: 2003-11 Impact factor: 9.162

10. Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.

Authors: Shanu Modi; Cristina Saura; Toshinari Yamashita; Yeon Hee Park; Sung-Bae Kim; Kenji Tamura; Fabrice Andre; Hiroji Iwata; Yoshinori Ito; Junji Tsurutani; Joohyuk Sohn; Neelima Denduluri; Christophe Perrin; Kenjiro Aogi; Eriko Tokunaga; Seock-Ah Im; Keun Seok Lee; Sara A Hurvitz; Javier Cortes; Caleb Lee; Shuquan Chen; Lin Zhang; Javad Shahidi; Antoine Yver; Ian Krop
Journal: N Engl J Med Date: 2019-12-11 Impact factor: 91.245

2 in total

Review 1. Radioembolization of Secondary Hepatic Malignancies.

Authors: Barbara Manchec; Nima Kokabi; Govindarajan Narayanan; Andrew Niekamp; Constantino Peña; Alex Powell; Brian Schiro; Ripal Gandhi
Journal: Semin Intervent Radiol Date: 2021-10-07 Impact factor: 1.780

2. Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study.

Authors: Elie Barakat; Andras Bibok; Anupam Rishi; Altan Ahmed; Jessica M Frakes; Sarah E Hoffe; Avan J Armaghani; Aixa E Soyano; Ricardo L B Costa; Ghassan El-Haddad; Junsung Choi; Bela Kis
Journal: Adv Radiat Oncol Date: 2021-10-29

2 in total